Acrivon Therapeutics ACRV
NASDAQ ACRV
$1.76 -0.07 (-3.83%)
At close: Oct 22, 2026 · 4:00 PM EDT

Acrivon Therapeutics (ACRV) Return on Sales [ROS] (2023 - 2026)

Updated

Analysis

Acrivon Therapeutics (ACRV) Return on Sales [ROS] (2023 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,140.91 Bn 1,109.50 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 634.46 Bn 554.32 Bn 17.30 Bn 24.35%
3 AbbVie 500.42 Bn 473.54 Bn 12.70 Bn 37.86%
4 Merck 355.19 Bn 309.56 Bn 12.21 Bn -3.52%
5 Novartis Ag 300.18 Bn 264.17 Bn 11.24 Bn 32.97%
6 Astrazeneca 263.17 Bn 236.86 Bn 12.86 Bn 20.57%
7 Amgen 237.83 Bn 193.23 Bn 7.24 Bn 34.95%
8 Gilead Sciences 193.81 Bn 168.01 Bn 6.22 Bn -133.21%
9 Pfizer 170.12 Bn 116.76 Bn 10.94 Bn 28.37%
10 Acrivon Therapeutics 71.96 Mn -363.57 Mn - -2,170.70%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -2,170.70%
Mar 31, 2026 -2,012.34%
Dec 31, 2025 -1,613.15%
Sep 30, 2025 -1,307.24%
Jun 30, 2025 -1,309.19%
Mar 31, 2025 -1,085.27%
Dec 31, 2024 -1,056.03%
Sep 30, 2024 -931.80%
Jun 30, 2024 -795.73%
Mar 31, 2024 -1,221.85%
Dec 31, 2023 -1,244.27%
Sep 30, 2023 -912.73%
Jun 30, 2023 -876.84%
Mar 31, 2023 -796.51%
API Access

Acrivon Therapeutics Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=ACRV&period=max&api_key=YOUR_API_KEY